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Several organs in the body comprise cells coupled into networks. These cells have in common that they are
excitable but do not express action potentials. Furthermore, they are equipped with Ca2+ signaling systems, which
can be intercellular and/or extracellular. The transport of small molecules between the cells occurs through gap
junctions comprising connexin 43. Examples of cells coupled into networks include astrocytes, keratinocytes,
chondrocytes, synovial fibroblasts, osteoblasts, connective tissue cells, cardiac and corneal fibroblasts, myofibroblasts,
hepatocytes, and different types of glandular cells. These cells are targets for inflammation, which can be initiated after
injury or in disease. If the inflammation reaches the CNS, it develops into neuroinflammation and can be of importance
in the development of systemic chronic inflammation, which can manifest as pain and result in changes in the
expression and structure of cellular components. Biochemical parameters of importance for cellular functions are
described in this review.
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Inflammation and neuroinflammation
In conditions that lead to inflammation, changes in sev-
eral cellular parameters of coupled cell networks occur
throughout many organs in the body. Inflammation is a
physiological response to injury that is designed to re-
move dangerous stimuli, kill bacteria and viruses, re-
move cell debris, and initiate healing. It can persist or
become exaggerated and may cause undesirable negative
effects. Inflammation can be induced by several substances
produced or released by tissues or by environmental fac-
tors, including circulating glucose, gut microflora, interleu-
kins, endotoxins or other toxins, all of which have an
impact on immune receptor expression. The underlying
molecular processes are just beginning to be elucidated.* Correspondence: elisabeth.hansson@neuro.gu.se
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unless otherwise stated.When an injury occurs in peripheral tissue, pro-
inflammatory mediators are released into the bloodstream,
and white blood cells are attracted to the injury site. The
endothelium lining the blood vessels becomes permeable,
allowing leukocytes to migrate from the blood vessels to
the injury site [1, 2]. The pro-inflammatory mediators re-
leased can increase the permeability of the blood–brain bar-
rier (BBB), leading to the passage of blood cells into the
central nervous system (CNS) [3, 4]. This process is known
as neuroinflammation [5]. These blood cells are trans-
formed into reactive microglia, which produce pro-
inflammatory cytokines and activate astrocytes. This
combined response causes a change in astrocyte network
signaling, which is involved in monitoring neuronal signal-
ing as well as rebuilding synapses [6].
Neuroinflammation can also be initiated when a local
peripheral injury gives rise to inflammatory activation in
the CNS at the site of the damaged or affected nerve(s)
[7–9]. The inflammatory cascade is activated, and im-
munocompetent cells migrate to the site of injury. Such
cells can be mast cells, which are capable of migratingOpen Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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promised as a result of CNS pathology [10]. Pericytes in
the microvessels respond to immune activation and may
play an important role in communicating inflammatory
signals [11]. Myofibroblasts, developed from fibroblasts
and maybe also from pericytes, are considered to be the
dominant collagen-producing cells and are activated
when structural and functional defects occur [12]. As a
result, the subsequent neuroinflammatory environment
causes the activation of glial cells located in the dorsal
horn of the spinal cord. Macrophages infiltrate the in-
jured nerve and cause an inflammatory reaction in the
neurons [13], which leads to microglial activation in the
CNS and pro-inflammatory cytokine release. These cy-
tokines then activate and alter astrocyte function [9, 14].
Once the astrocytes and microglia have been activated,
they participate in the development, spread, and po-
tentiation of neuroinflammation [15, 16], resulting in
low-grade inflammation [7] along the pain pathways
from the periphery to the spinal cord, extending up to
the thalamus and farther onto the parietal cortex.
If this dysfunction persists for a long time, it can lead
to pathogenic chronic neuroinflammation and can tran-
sition into long-term pain [8, 9, 17]. When an inflamma-
tory response is activated throughout the body, the
event can affect non-lesioned structures on both the ip-
silateral and contralateral sides [18].
Coupled cell networks
Similarities exist between different types of coupled cell
networks in different body organs with respect to several
cellular parameters. Examples of cells coupled into net-
works include astrocytes, keratinocytes, chondrocytes,
synovial fibroblasts, osteoblasts, connective tissue cells,
cardiac and corneal fibroblasts, myofibroblasts, hepato-
cytes, and different types of glandular cells (Fig. 1). Inter-
cellular communication gives tissues the ability to
coordinate many cellular functions such as the regula-
tion of cell volume, intracellular ionic composition, and
cell metabolism. Characteristics such as their passive
electrical properties not only provide the framework and
metabolic support for different organs but also contrib-
ute to their computational power and behavioral output.
These properties enable more active functions and are
endowed through Ca2+-based excitability [19]. Intracellular
Ca2+ changes are important due to their influence on many
cell functions, including matrix synthesis and degradation
[20]. An increase in cytosolic Ca2+ levels can lead to the re-
lease of signaling molecules such as transmitters, cytokines,
prostaglandins, proteins, and peptides via regulated exocyt-
osis [21]. The dynamic components of exocytosis include
the vesicular-plasma membrane secretory machinery and
vesicular traffic, which is governed by general cytoskeletal
elements [22]. For this machinery to work, intercellularstructures called gap junctions, which directly connect the
interior of adjacent cells through a pathway not open to the
extracellular space, appear necessary [23]. Gap junction
channels comprise two hemichannels, called connexons,
one of which is provided by each of the joined cells. These
channels select for the direct exchange of ions, metabolites,
and small molecules such as Ca2+, adenosine triphosphate
(ATP), nicotinamide adenine dinucleotide (NAD+), glutam-
ate, prostaglandins, and glutathione, which are less than
1.5 kDa in size, between contiguous cells [24]. Connexin 43
(Cx43) is the primary gap junction protein [25]. Cytoskel-
etal reorganization is pivotal event in all of these pro-
cesses; dynamic remodeling of the actin cytoskeleton plays
an essential role in cell migration and proliferation. Actin
appears in two forms, globular actin (G-actin) and fila-
mentous actin (F-actin), and the transition between these
two forms is a dynamic process driven by polymerization
and depolymerization [26] (Fig. 2).
Coupled cell networks in different body organs
Astrocytes
The well-studied cells coupled into networks are astro-
cytes in the CNS [6, 21]. Astrocytes in networks posi-
tioned between the vasculature and synapses monitor
neuronal signaling and synapse rebuilding [6]. Astrocytes
express nearly the same repertoire of receptors and ion
channels as neurons, regulate synaptic transmission via
bidirectional communication with neurons, and release
gliotransmitters and other factors such as cytokines,
fatty acid metabolites, and free radicals [27, 28].
Because they do not communicate via action potentials,
astrocytes are not electrically active; however, they display a
form of excitability that manifests as an increased intracel-
lular Ca2+ concentration. Stimuli such as transmitters re-
leased from neurons and glial cells can evoke Ca2+
elevation in single astrocytes, which passes to adjacent as-
trocytes and leads to a Ca2+ wave that can propagate over
long distances, albeit much more slowly than the propaga-
tion of action potentials in neurons [19, 29, 30].
Incoming stimuli activate G protein-coupled receptors
that hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP2)
and cause the release of inositol 1,4,5-trisphosphate (IP3)
into the cytosol. IP3 receptors located on the endoplasmic
reticulum respond to this elevation of IP3 by releasing
Ca2+. Cytosolic Ca2+ plays a key role as a second messen-
ger; thus, the control of Ca2+ signals is critical. This control
involves coordinating Ca2+ entry across the plasma mem-
brane, Ca2+ release from the endoplasmic reticulum, endo-
plasmic reticulum store refilling, and Ca2+ extrusion across
the plasma membrane [31]. The Na+-Ca2+ exchanger, a
Ca2+ transporter that controls the intracellular Ca2+
concentration, is driven by the Na+ electrochemical gradi-
ent across the plasma membrane.This Na+ pump, the
Na+/K+-ATPase, indirectly modulates Ca2+ signaling [32],
Fig. 1 Schematic illustration highlighting the different organs in the body that comprise cells coupled into networks. These cells are excitable but
do not express action potentials. They are equipped with Ca2+ signaling systems, and the transport of small molecules between the cells occurs
through gap junctions. Examples of cells coupled into networks are astrocytes in the brain, keratinocytes in the skin and buccal membranes,
chondrocytes in the articular cartilage, osteoblasts in bone, connective tissue cells such as epithelial cells in the cornea and tenocytes in the
ligaments, cardiac fibroblasts in the heart, hepatocytes in the liver, and different types of glandular cells throughout the body. The illustration was
created by Pontus Andersson, ArtProduction, Gothenburg, Sweden
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astrocyte networks [33–35].
Astrocytes are directly connected to adjacent cells by
gap junctions, and Cx43 is the primary gap junction pro-
tein [25]. Astrocytes also express hemichannels that
open exteriorly; Cx43 appears to also be the main Cx
found in these hemichannels [24]. Astrocytes in most
parts of the CNS use two types of Ca2+ communication:intercellular communication through gap junctions and
extracellular communication through the diffusion of
ATP, which then binds to purinoceptors. Both inter- and
extracellular Ca2+ communication occur in many parts
of the cerebrum [19, 36]. In the retina, intercellular
communication occurs through astrocytes, but extracel-
lular communication occurs between astrocytes and
Müller cells [37].
Fig. 2 Schematic illustration of three cells coupled in networks under physiological conditions. The cells are coupled by gap junctions to form
extensive cellular networks. Receptors, ion pumps, glutamate transporters, actin filaments (white bands), cytokine release and Ca2+ signaling
are shown. Cytosolic Ca2+ plays key roles as a second messenger and a sensor of Ca2+-dynamics in cell networks and detects changes in the
microenvironment. Two communication pathways exist: the major intercellular via gap junctions comprising Cx43. Receptors on the surface of cells
are coupled to G proteins and release Ca2+ from the endoplasmic reticulum via PLC and IP3. Ca
2+ elevations are followed by the propagation of
intercellular Ca2+ waves through the gap junctions, which are also permeable to molecules less than 1.5 kDa such as Ca2+, IP3, and cAMP. The minor
extracellular pathway involves ATP release through hemichannels. The illustration was created by Pontus Andersson, ArtProduction,
Gothenburg, Sweden
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membrane microdomains and the endoplasmic reticulum
complex. The adaptor protein ankyrin B is associated with
the Na+ pump as well as with endoplasmic reticulum pro-
teins such as IP3. The primary cytoplasmic matrix proteins
spectrin and actin are attached to ankyrin B. An intact
cytoskeleton is required for astrocytic Ca2+ wave propaga-
tion [36], and cytoskeletal disruption abolishes Ca2+ oscil-
lations by changing the balance of the Ca2+ regulatory
processes [38].
Astrocytes contribute to the homeostasis and regulation
of extracellular glutamate levels. The glutamate-glutamine
cycle is a well-known process through which glutamine is
released from astrocytes and taken up by glutamatergic or
γ-aminobutyric acid (GABA)ergic neurons. Glutamine is
then converted to glutamate in neurons and released into
the synaptic space. The majority of the released glutamate
is taken up by astrocytes through the glutamate trans-
porters; glutamate/aspartate transporter (GLAST/excitatory
amino acid transporter 1, EAAT1), and glial glutamate
transporter-1 (GLT-1/EAAT2) and then metabolized by
glutamine synthetase to glutamine [39, 40].
Keratinocytes
The epidermis is a dynamic, stratified structure formed by
continually proliferating and differentiating keratinocytesthat surround the sensory nerve endings of several C- and
Aδ-fiber subtypes. The skin and buccal membrane primar-
ily comprise keratinocytes, the epidermis. The cells are con-
nected by well-developed intercellular junctions such as
gap junctions. Within these gap junctions, Cx43 is associ-
ated with the regulation of cell proliferation and mediates
forms of intercellular communication in which ions and
small molecules are allowed to pass from one cell to an-
other. Cx43 is primarily localized to the lower epithelial
layer, the stratum basale and stratum spinosum [41]. Cx43
degradation is thought to play a role in the differentiation
of the gingival epithelium. Properly regulated gap junctions
appear to be essential for efficient wound healing and for
protection against skin diseases. Human epidermal kerati-
nocytes use intercellular Ca2+ signaling. G protein-coupled
receptors, which activate phospholipase C (PLC) and con-
vert PIP2 into diacylglycerol and IP3, trigger the release of
Ca2+ from intracellular Ca2+ stores [42, 43].
In response to stress, injury or even chronic pain, kerati-
nocytes can release ATP through hemichannels, resulting
in Cx43 upregulation. Metabotropic purinergic (P2Y2) re-
ceptors are then activated, resulting in increased intracellu-
lar Ca2+ [44]. ATP release is an important signal for
epidermal homeostasis and influences keratinocyte prolifer-
ation and differentiation [45]. Glutamate-mediated signal-
ing is observed in keratinocytes in the epidermis, and
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N-methyl-D-aspartate receptor (NMDA), α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
(AMPA) and metabotropic glutamate receptors, as
well as transporters such as EAAT1 have been identi-
fied in the basal layer. Additionally, GLT-1 has been
found in the suprabasal layer [46].
Chondrocytes
Chondrocytes are connected to each other via cell-to-
cell interactions and form functional gap junctions that
express Cx43 [47, 48]. They can sustain the propagation
of intercellular Ca2+ waves in rabbits [47], humans, and
equines [49, 50] and can also form hemichannels that
exchange signals within the extracellular space [51]
(Skiöldebrand et al., unpublished). Articular chondro-
cytes accumulate intracellular IP3 following mechanical
stimulation, causing the diffusion of IP3 into adjacent
cells through gap junctions and amplification of the re-
sponse. In adult articular cartilage, chondrocytes exist as
individual cells embedded in the extracellular matrix,
and gap junctions are mainly expressed by the flattened
chondrocytes facing the outer cartilage layer where
intercellular communication occurs [52]. The role of
Cx43 in chondrocytes has not been extensively studied,
but Cx43 is required for the differentiation and meta-
bolic homeostasis of the extracellular matrix [48]. Cx43
also functions as a hemichannel to release ATP and
NAD+. Chondrocytes express purinergic receptors such
as P2-purinoceptors that induce intracellular Ca2+ re-
sponses. These intracellular Ca2+ responses are increased
following stimulation with IL-1 [53]. Glutamate and sub-
stance P have been identified in human articular chon-
drocytes. Neurokinin 1 (NK1) and glutamate receptors
are also expressed, as well as both metabotropic and
ionotropic glutamate receptors and the glutamate trans-
porters GLT-1 and GLAST [54].
Bone cells
Gap junctional communication plays a critical role in
the coordination of bone remodeling. The bone-forming
cells osteoblasts and osteocytes primarily express Cx43
but also express Cx45 and Cx46, which form functional
gap junctions [55]. Cx43 expression increases during dif-
ferentiation, and inhibition of this communication leads
to retardation of the differentiation process, resulting in
a reduced ability to form mineralized extracellular
matrix. Through mechanical manipulation, the osteo-
blasts, which are non-excitable, produce synchronized
Ca2+ waves, which involve the release of IP3-sensitive
intracellular Ca2+ stores. These waves occur either via
gap junction-mediated intercellular Ca2+ signaling or as
a result of the autocrine activity of released ATP, which
stimulates P2 purinoceptors. The P2Y class comprises Gprotein-coupled receptors that activate PLC, resulting in
IP3 generation and intracellular Ca
2+ store release in hu-
man osteoblasts [56]. Hemichannels have also been re-
ported in osteoblasts [55].
Connective tissue cells
Gap junctions are found in tendons, ligaments, synovium
(within the synovial membrane), and corneal stroma
because the cells of these tissues are coupled to form
networks. Two adjacent cells join through Cx43, allowing
direct cell-to-cell communication via Ca2+ signaling.
In osteoarthritis, the synovial fibroblasts produce pro-
inflammatory cytokines and catabolic proteases, leading to
degradation of the extracellular matrix. The role of Cx43 in
osteoarthritis involves an increase in its expression in both
chondrocytes and synovial cells, which affects catabolic
and pro-inflammatory genes [57]. Tenocytes respond to
mechanical signals by transforming them into biochemical
signals via a second messenger such as Ca2+ or IP3 [58].
The mechanical load directly regulates gap junction per-
meability [59]. Some of the Cxs assemble to form hemi-
channels [60]. Through mechanical stimulation, ATP is
released and acts in a paracrine or autocrine manner
through the stimulation of P2Y2 purinoceptors, resulting in
increased intracellular Ca2+ [58]. Cx43 associates with actin
to stabilize gap junctions at the plasma membrane [61].
Cardiac fibroblasts
Cardiac fibroblasts are the most abundant cell type in the
heart, play a key role in the myocardial maintenance and
repair, and can transform into cardiac myofibroblasts,
which are present in valve leaflets in the adult heart. These
cells express α-smooth muscle actin (α-SMA) and are re-
ferred to as α-SMA-containing stress fibers [62]. The cells
are joined by gap junctions that express Cx43 [63], enab-
ling Ca2+ signaling that causes the release of Ca2+ from
the endoplasmic reticulum in response to ATP, histamine,
5-hydroxytryptamine (5-HT) [64] (Lundqvist et al., un-
published), or bradykinin [65]. These cells produce extra-
cellular matrix, exhibit high Na+/K+-ATPase activity levels
in the extracellular matrix [66], and also produce and re-
lease a substantial number of cytokines and growth factors
into their environment, thereby regulating cell function in
an autocrine and paracrine manner [62].
Hepatocytes
Agonist-evoked Ca2+ signals are found in the liver and are
manifested as the propagation of intercellular Ca2+ waves
through liver cells called hepatocytes. Agonist binding to
plasma membrane receptors stimulates Gq proteins, which
activate PLC and cause Ca2+ mobilization from internal
stores [67]. The intercellular propagation normally takes
place through Cx43-containing gap junctions [68]. ATP
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tors, a paracrine signaling pathway [69].
Glandular cells
Intercellular signaling in salivary glands has been observed
when 5-HT triggers intercellular Ca2+ waves through gap
junctions and induces Ca2+ release via the IP3 receptor
[70]. Pancreatic acinar cells in the exocrine part of the gland
also conduct intercellular Ca2+ signaling between cells [71].
Inflammation at the cellular level
During inflammation, the expression and affinities of
several receptors are changed. In astrocytes, Toll-like re-
ceptor 4 (TLR4) expression increases [72, 73], and opi-
oid receptors alter their responses to agonists and
antagonists [74, 75].
Furthermore, the cytoskeleton is disrupted into more dif-
fuse and ring-structured actin filaments. Lipopolysaccharide
(LPS) exposure alters the actin cytoskeleton in astrocytes
[73], macrophages [76], neutrophils [77], and pulmonary
monocytes [78]. Ca2+ signaling in the astrocyte network is
elevated, resulting in increased ATP production and release
through the opening of hemichannels. ATP stimulates puri-
noceptors through autocrine or paracrine mechanisms andFig. 3 In cells experiencing inflammation, glutamate release into the extrac
over-activated. Several receptors are influenced by the increased expression
are also changed. The Na+/K+-ATPase is downregulated, the glutamate tran
bands disorganized) in the cytoskeleton are reorganized, thereby abolishin
leads to the down-regulation of intercellular Ca2+ signaling and thereby of
P2 purinoceptors, which generates extracellular Ca2+ oscillations/waves and
pro-inflammatory cytokines such as IL-1β occurs extracellularly. The clearing
which plays a critical role in preventing glutamate excitotoxicity, is attenua
Gothenburg, Swedenresults in increased Ca2+ release from internal stores; this
release occurs in the form of Ca2+ oscillations, which may
change the balance of Ca2+-regulating processes [21]. This
extracellular Ca2+ signaling attenuates intercellular Ca2+
signaling, causing reduced communication via gap junc-
tions [79]. Sodium transporters such as the Na+/K+-ATPase
are downregulated [73]. Neuronal excitability is increased
due to the inflammation, leading to increased glutamate re-
lease at neural synapses. Astrocytes are the predominant
players in clearing glutamate from the extracellular space.
The uptake of excessive extracellular glutamate by astro-
cytes via the membrane-bound glutamate transporters
GLAST and GLT-1 plays a critical role in preventing glu-
tamate excitotoxicity [80]. Glutamate uptake transporters
are downregulated in the presence of excess glutamate,
which leads to the inhibition of glutamate uptake [81]. The
increased release of pro-inflammatory cytokines such as
tumor necrosis factor-α (TNF-α) and IL-1β also occurs
[72, 73, 82, 83] (Fig. 3).
Inflammation plays a part in most, if not all, CNS in-
sults. Examples of inflammatory diseases where some of
these cellular parameters have been shown to be chan-
ged are in the Alzheimer’s disease [84], Parkinson’s dis-
ease [85], multiple sclerosis [86], traumatic injury andellular space is increased, and Ca2+ signaling in cellular networks is
of TLR4, and the responses of other receptors such as P2 and mGluR5
sporters GLT-1 and GLAST are changed, and actin filaments (white
g the balance between the Ca2+ regulatory processes. This process
Cx43 in gap junctions. ATP is released from the cells and binds to
increased release from internal stores. The increased release of
of increased glutamate concentrations from the extracellular space,
ted. The illustration was created by Pontus Andersson, ArtProduction,
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diseases where immune and inflammatory cells have
crucial roles in these responses [87].
Changes in cellular parameters due to inflammation
are also observed in other cellular networks.
The cellular location of TLR4 in keratinocytes has a key
role in the initiation of innate immunity and in the regula-
tion of adaptive immune responses. TLR4 may also be an
important regulator of wound inflammation [88] and der-
mal wound healing [89]. Keratinocytes play a role in the
pathogenesis of cutaneous inflammatory disease by produ-
cing pro-inflammatory cytokines such as IL-1α, IL-1β,
TNF-α, IL-6, IL-8 and granulocyte-macrophage colony-
stimulating factor, adhesion factors, and co-stimulatory
molecules [90].
In rheumatoid arthritis, the synovial lining cells exhibit
an infiltration of macrophages, increased levels of pro-
inflammatory cytokines, and upregulation of catabolic
matrix-degrading enzymes such as matrix metalloprotein-
ases, which leads to the activation and destruction of cartil-
age and bone cells. An interaction between LPS, TLR4, and
collagen type II in chondrocytes has a role in initiating this
pro-inflammatory activity and can lead to the inhibition of
cartilage extracellular matrix production and chondrocyte
inflammation and apoptosis [91]. The stimulation of chon-
drocytes with IL-1β causes the significant up-regulation of
TLR4 [92], increased production of metalloproteinases,
suppression of type II collagen and proteoglycan produc-
tion and induction of pro-inflammatory mediators such as
prostaglandins and nitric oxide [49]. The degradation of ar-
ticular cartilage is a characteristic feature of arthritic dis-
eases, and IL-1 is one of the more potent cytokines that
promotes cartilage catabolism, enhances Cx43 expression
and increases Ca2+ signaling [47]. Altered Cx43 expression
may be an early phenotypic event in osteoarthritis [48].
The concentration of glutamate in synovial fluid is
notably increased in both osteoarthritis (a low-grade
inflammatoryjoint disease) and rheumatoid arthritis
(a chronic autoimmune disease) and is correlated with
increased inflammatory mediators such as TNF-α and
chemokines [93].
The increased extracellular glutamate concentration is
regulated by glutamate transporters in rat chondrocytes
[94] as well as in human cartilage [54]. Glutamate may
function as an autocrine factor. Ionotropic glutamate
receptors contribute to pain and the inflammatory stages
of osteoarthritis, and receptor antagonists have been pro-
posed as a potential treatment [95]. Adenosine receptors
have important roles in the regulation of inflammation
and may be involved in the inhibition of pro-inflammatory
cytokine release, especially in chondrocytes and osteo-
blasts [96].
Cardiac fibroblasts likely have important roles in the in-
flammatory process in the heart. These cells transform intomyofibroblasts in conditions of reduced ventricular func-
tion; extracellular matrix production is increased, chemo-
kine production is upregulated, and inflammatory pathways
are changed. Furthermore, these fibroblasts recruit mono-
cytes into cardiac tissue [97]. Mechanical stress, which also
induces increased chemokine production, appears to be im-
portant in the inflammatory process.
During pathophysiological inflammation in salivary
gland cells, LPS induces the secretion of IL-β into the
saliva. TLR4 is upregulated via the LPS signaling path-
way [98]. Inflammation in the mammary gland during
lactation leads to TLR4 activation and increased IL-8 se-
cretion [99]. Inflammation in the lacrimal gland results
in up-regulation of TLR4 in the corneal epithelium of
the eye [100].
TLR4 may be involved in the immune response in liver
disease caused by hepatitis B, which can lead to inflam-
mation, cirrhosis, and hepatocellular carcinoma [101].
Airway inflammation is often caused by Gram-negative
bacteria or by the presence of endotoxins, which can lead
to the development of asthma. TLR4 also seems to play an
important role in this process [102].
Systemic inflammation and the spread of
inflammation
Do coupled cell networks in different organs possess a
signaling system that can spread or propagate from the
coupled cell networks of one organ to those in other or-
gans on either the contralateral or ipsilateral side? Can
chronic, low-grade, systemic inflammation influence
coupled cell networks in one or several organs, leading
to chronic tissue degradation?
Obesity promotes chronic, low-grade, systemic inflam-
mation that contributes to the development of type 2 dia-
betes, cardiovascular disease and metabolic disorders such
as liver steatosis [103, 104]. Both the intestinal microbiota
and a high-fat diet have been shown to induce changes in
gut homeostasis and consequent mucosal inflammation.
Intestinal inflammation may be an early event that leads
to the systemic inflammation of several organs [105]. Fur-
thermore, there appear to be strong links between type 2
diabetes, dementia and neurodegenerative diseases such
as Alzheimer’s disease. Underlying mechanisms involved
seem to be defaults in cellular insulin resistance, inflam-
matory and oxidative stress pathways [106]. Additional
autoimmune rheumatic diseases are thought to result in
both joint and systemic inflammation, with TNF-α acting
as the prominent cytokine. This process may be an initi-
ator of neuroinflammation [5] and might increase the risk
of cardiovascular tissue destruction [107]. Transient recep-
tor potential (TRP) channels, expressed in non-excitable
coupled cell networks [108, 109] play important roles in
physiological as well as in pathological processes; inflamma-
tion and pain. They activate signal pathways via Ca2+ entry
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ume regulation and are involved in diseases such as osteo-
arthritis, cardiovascular disorders, type 2 diabetes mellitus
etc. [108, 110, 111]. Stimulation of TRP channels can lead
to astrocytic reactions followed by activation of nociceptive
input [109]. Osteoarthritis is a condition characterized by
mainly pain, reduced joint movement and signs of inflam-
mation, such as swelling. TRP channels antagonists have
been investigated as a novel therapy by alleviating pain and
some inflammatory aspects [112].
Innate immune dysregulation can be the driver for auto-
inflammatory diseases. It is efforts to define overlapping,
maybe genetically determined inflammatory responses in
autoimmunity and infection diseases [113]. These questions
are important to reflect on, and more studies are required
to obtain more conclusive answers.Pain processing and mirror pain due to
neuroinflammation
CNS glia, especially microglia and astrocytes coupled
into networks, appear to be capable of action at a dis-
tance. The nervous system can also initiate signals that
alter the function of glial cells. Activated glia release
immunomodulatory products, which can be key media-
tors of the modulation of neuronal activity. It may lead
to low-grade inflammation at the site of the damaged
or affected peripheral nerve(s). Inflammatory receptors
are affected, and interactions between these receptors
may induce immune signaling changes, which may be
of importance in neuroinflammation. Such immune-
mediated inflammation can be underlying mechanisms
of persistent or long-term pain. Astrocytes and micro-
glia become activated after pain-activating substances
are released from neurons located in the spinal cord
and brain in response to peripheral and/or CNS
trauma, which can lead to over-activation [7] that re-
sults in morphological and functional changes. Add-
itionally, sodium transporters down-regulation and
cytoskeletal disruption occur, thereby abolishing Ca2+
signaling by altering the balance between Ca2+-regulat-
ing processes [114].
Changes in the release of pro- and anti-inflammatory
cytokines are observed in many clinical studies [83, 115].
These mediators can underlie the spread of the neuroin-
flammation and pain to the uninjured side [8]. Effects
on contralateral non-lesioned structures have been well-
documented, and these effects also occur on the ipsilat-
eral side. Unidentified signaling mechanisms linking
either the same side of the body or the two sides of the
body likely exist [18]. Glial cells and potentially astro-
cytes can participate in the activation and initiation of
signals that regulate neuronal function but may also ini-
tiate signals in other parts of the body.Conclusion
Coupled cell networks throughout the body are coupled
by gap junctions expressing Cx43 and Ca2+ signaling
systems. These cells are targets in conditions that can
lead to immune-mediated inflammation. Several basal
cellular parameters are then changed. One hypothesis is
that coupled cell networks use a signaling mechanism
between the cells within their own networks. The signal-
ing can be transferred to other coupled cell networks in
other organs. This form of communication may give rise
to inflammatory systemic diseases. Such signaling may
facilitate the spreading of pain to sites both contralateral
and ipsilateral to the original injury site; this spreading is
sometimes observed with long-term pain.
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Highlights
Inflammatory processes result in biochemical changes and altered functions in
coupled cell networks in different organs in the body.
Coupled cell networks express gap junctions comprising connexin 43 and
inter- and/or extracellular Ca2+ signaling systems.
Signaling between coupled cell networks can facilitate the spread of
inflammation, which can lead to pain and pain spreading on both the
ipsilateral and contralateral sides if nervous tissue cells are involved.
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